{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:14:07Z","timestamp":1783577647236,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ejmg.2015.10.014","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T16:06:46Z","timestamp":1446221206000},"page":"681-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology"],"prefix":"10.1016","volume":"58","author":[{"given":"Eric","family":"Caudron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Prognon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique P.","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2015.10.014_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.gene.2012.01.056","article-title":"A\u00a0variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy","volume":"497","author":"Al-Thihli","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.ejmg.2015.10.014_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnostic on dried blood spot in filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmg.2015.10.014_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1373\/clinchem.2008.111864","article-title":"Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders","volume":"55","author":"De Jesus","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejmg.2015.10.014_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.ejmg.2015.10.014_bib5","article-title":"X-chromosome inactivation in female patients with Fabry disease","author":"Echevarria","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejmg.2015.10.014_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase a\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmg.2015.10.014_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1536\/jhj.45.179","article-title":"Comparison of two tests for serum alpha-galactosidase in non-neuromuscular left ventricular hypertrabeculation\/concompaction","volume":"45","author":"Finsterer","year":"2004","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.ejmg.2015.10.014_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","article-title":"Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders","volume":"29","author":"Gelb","year":"2006","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmg.2015.10.014_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orph. J. Rare Dis."},{"key":"10.1016\/j.ejmg.2015.10.014_bib10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","article-title":"Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease","volume":"18","author":"Germain","year":"2007","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.ejmg.2015.10.014_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1750-1172-7-91","article-title":"Safety and pharmacodynamic effects of a pharmacological chaperone on \u03b1-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies","volume":"24","author":"Germain","year":"2012","journal-title":"Orph. J. Rare Dis."},{"key":"10.1016\/j.ejmg.2015.10.014_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","article-title":"Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease","volume":"52","author":"Germain","year":"2015","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.014_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/hrt.2010.200188","article-title":"Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study","volume":"97","author":"Hagege","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ejmg.2015.10.014_bib14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936\u00a0+\u00a0919G\u00a0>\u00a0A (IVS4\u00a0+\u00a0919G\u00a0>\u00a0A)","volume":"30","author":"Hwu","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmg.2015.10.014_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.10.019","article-title":"Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers","volume":"353","author":"Linthorst","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmg.2015.10.014_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2009.072116","article-title":"Screening for Fabry disease in high-risk populations: a systematic review","volume":"47","author":"Linthorst","year":"2010","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.014_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10545-005-0039-4","article-title":"The ratio of alpha-galactosidase to beta-glucuronidase activities in dried blood for the identification of female Fabry disease patients","volume":"28","author":"Lukacs","year":"2005","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmg.2015.10.014_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s10545-007-0679-7","article-title":"Direct comparison of enzyme measurements from dried blood and leukocytes from male and female Fabry disease patients","volume":"30","author":"Lukacs","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmg.2015.10.014_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmg.2015.10.014_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4155\/bio.10.73","article-title":"Performance properties of filter paper devices for whole blood collection","volume":"2","author":"Mei","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejmg.2015.10.014_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2010.09.008","article-title":"Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots","volume":"102","author":"Oemardien","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejmg.2015.10.014_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"J.\u00a0Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejmg.2015.10.014_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2011.07.014","article-title":"The use of dried blood spot samples in the diagnosis of lysosomal storage disorders - current status and perspectives","volume":"104","author":"Reuser","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejmg.2015.10.014_bib24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejmg.2015.10.014_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2011.01.006","article-title":"Improved assay for differential diagnosis between Pompe disease and acid \u03b1-glucosidase pseudodeficiency on dried blood spots","volume":"103","author":"Shigeto","year":"2011","journal-title":"Mol. Genet. Metab."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721215300380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721215300380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:42:21Z","timestamp":1761709341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721215300380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1769721215300380"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2015.10.014","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2015.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}